RxDoctor Payments Data

Candice Bertsch

Family · Dothan, ALNPI 1841920030

Payments from drug & device makers

$8,208in general payments, 2019–2025

Across 397 payments — averaging $20.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Incyte Corporation$709
  • Genentech USA, Inc.$446
  • Johnson & Johnson$431
  • Novartis$428
  • Regeneron Healthcare Solutions, Inc.$342
  • Merck$330
  • plus $5K from 54 others

What the payments were for

  • Food & beverage$8,174100%
  • Education$340%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Incyte Corporation30$709
Genentech USA, Inc.23$446
Johnson & Johnson25$431
Novartis21$428
Regeneron Healthcare Solutions, Inc.14$342
Merck16$330
AstraZeneca(2 entities)18$326
Lilly USA, LLC15$274
Takeda Pharmaceuticals U.S.A., Inc.12$262
Daiichi Sankyo Inc.12$251
Bristol Myers Squibb9$221
Eagle Pharmaceuticals, Inc.4$208
Sanofi8$192
Seagen Inc.11$169
Pfizer11$160
Ipsen Biopharmaceuticals, Inc7$148
Myriad Genetic Laboratories, Inc.3$141
AbbVie6$136
Array Biopharma Inc9$126
Bayer6$125
Novo Nordisk1$119
E.r. Squibb & Sons, L.L.C.5$108
Eisai Inc.6$103
Pharmaessentia USA Corporation4$103
AVEO Pharmaceuticals, Inc.5$100
United Therapeutics Corporation1$97
Deciphera Pharmaceuticals Inc.4$93
Beigene USA, Inc.5$89
Exelixis Inc.5$88
Genmab U.S., Inc.5$83
Puma Biotechnology, Inc.4$80
ADC Therapeutics America, Inc.4$78
Sobi, Inc3$76
Stemline Therapeutics Inc.4$73
Coherus Oncology, Inc.3$71
Beone Medicines USA, Inc.3$69
Dendreon Pharmaceuticals LLC3$68
Rigel Pharmaceuticals, Inc.4$68
Boehringer Ingelheim3$67
Jazz Pharmaceuticals Inc.3$67
Acrotech Biopharma Inc.4$67
Spectrum Pharmaceuticals Inc.4$67
Pharmacosmos Therapeutics Inc.3$60
Sumitomo Pharma America, Inc.4$59
G1 Therapeutics, Inc.3$57
Servier Pharmaceuticals LLC3$52
Karyopharm Therapeutics Inc.3$51
Myovant Sciences Inc.3$51
Gilead(2 entities)2$46
Adaptive Biotechnologies Corporation3$45
Mirati Therapeutics, Inc.3$45
Taiho Oncology, Inc.3$44
Agios Pharmaceuticals, Inc.2$42
EMD Serono, Inc.2$39
Boston Scientific2$38
Kyowa Kirin, Inc.2$38
Morphosys, US Inc.2$35
HEMA Biologics, LLC2$34
Astellas Pharma US Inc2$30
Immunogen, Inc.1$25

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,208 in reported general payments places this provider in the 95th percentile of 3,415 family providers in Alabama.

See all family providers in Alabama

Medicare billing

Part B allowed, 2024
$17,872
Medicare patients
149
Services billed
197

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Anastrozole61$1,578
Prochlorperazine Maleate24$487
Dexamethasone22$318
Hydroxyurea16$295
Ondansetron Hcl26$293
Acyclovir11$222
Tamoxifen Citrate12$198
Letrozole11$174
Venlafaxine Hcl ErVenlafaxine Hcl13$144

Paid to pharmacies, not to this prescriber.

Other family in Dothan

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →